We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Intro slide
- Outline
- Causes of late onset dementia
- Causes of early onset dementia
- The size of the problem
- Risk factors for AD
- Familial AD (1)
- Familial AD (2)
- How common are AD gene mutations?
- What are the earliest pathological changes in AD?
- Site of hippocampus in the medial temporal lobe
- Evolution of tangles in AD
- Staging of neurofibrillary tangles in AD
- Cognitive features of AD (1)
- CANTAB PAC task
- PAL: errors at 6-pattern stage at presentation
- Autobiographical memory in AD and FTD
- Cognitive features of AD (2)
- Cognitive features of AD (3)
- Cognitive features of AD (4)
- Neuropsychiatric features of AD
- AD: Diagnostic Criteria
- Pre-dementia AD
- Criteria for MCI
- Diagnostic methods
- Cambridge MCI study
- PAL: errors at 6-pattern stage at presentation
- Conversion to AD on follow up
- PAL: outcome at 36 months at presentation
- Predictors of conversion
- Imaging
- Structural brain imaging: MRI
- 3D T1-W MRI: measurement of regions of interest
- Hippocampal volumes overlap
- Serial coregistration of MRI
- Patient with early AD: MRI - hippocampus
- 12 months later: MRI - hippocampus shrinkage
- Atrophy rates: 12 patients with AD and 14 controls
- FDG-PET + MRI coregistration
- Method
- FDG-PET finding in MCI and AD
- The posterior cingulate: BA 31/23/29/30
- Metabolic PET studies: summary
- Atypical presentations
- Potential aims of treatment
- Delay of symptomatic decline
- Drug treatments for dementia
- General principal underlying the use of AChEi
- The bottom line
- Cholinesterase inhibitors
- Management
Topics Covered
- Basic epidemiological facts on AD
- Typical and atypical symptoms
- Cognitive and physical findings
- Key clinical investigations typically undertaken
- Broad therapeutic approaches
- Natural history and prognosis
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Hodges, J. (2007, October 1). Alzheimer's disease (AD) [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 3, 2024, from https://doi.org/10.69645/MEOP5984.Export Citation (RIS)
Publication History
Financial Disclosures
- Prof. John Hodges has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.